Riskpilot← Back to searchSign inGet full accessCUSPIS AB
ABActiveOrg 5569064198Älgvägen 10General medical practice activities · NACE 8621Est. 20120 employees
Revenue 2024
SEK 543K
-2% vs 2023
EBITDA margin
89.6%
+34% vs 2023
Equity ratio
76.5%
Financial strength
Net profit 2024
SEK 436K
+344% vs 2023
| Revenue | SEK 543K | -2% |
| EBITDA | SEK 486K | +34% |
| Net profit | SEK 436K | +344% |
| Total assets | SEK 1,3M | +31% |
| Equity | SEK 1M | +75% |
| Employees | 0 | — |
Legal name
CUSPIS AB
Org number
5569064198
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 oktober 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska bedriva medicinsk konsultverksamhet inom internmedicin och kardiologi. Värdepappershandel samt äga och förvalta fast egendom.
Address
Älgvägen 10
Email
larserikstrandberg@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 640 | 709 | 431 | 553 | 543 |
| Staff expenses | — | — | −135 | −132 | −0 |
| EBITDA | 538 | 484 | 207 | 362 | 486 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 538 | 484 | 207 | 362 | 486 |
| Net financials | −478 | −94 | −554 | −190 | 51 |
| Profit before tax | 298 | 533 | −346 | 173 | 537 |
| Tax | −115 | −104 | −44 | −75 | −101 |
| Net profit | 183 | 429 | −390 | 98 | 436 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 588 | 1 895 | 1 107 | 1 019 | 1 331 |
| Equity | 1 030 | 1 276 | 680 | 583 | 1 019 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 559 | 619 | 427 | 436 | 313 |
| Total debt | 559 | 619 | 427 | 436 | 313 |
EBITDA margin
89.6%
This company
15.8%
Market median
+467% vs market
20202024
Equity ratio
76.5%
This company
38.2%
Market median
+100% vs market
20202024
Return on equity
42.8%
This company
18.4%
Market median
+133% vs market
20202024
Net profit margin
80.4%
This company
8.1%
Market median
+893% vs market
20202024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CUSPIS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marina Elisabet Strandberg | Board of Directors | 0 companies |
| Lars Erik Ragnar Strandberg | Chairman | 0 companies |
| Teodor Joon Soo Strandberg | Deputy Board Member | 0 companies |